American International Group Inc. reduced its holdings in Laboratory Corp. of America Holdings (NYSE:LH) by 1.0% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 47,896 shares of the medical research company’s stock after selling 504 shares during the quarter. American International Group Inc.’s holdings in Laboratory Corp. of America were worth $7,956,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the company. Key Financial Inc bought a new stake in Laboratory Corp. of America during the first quarter valued at about $26,000. Harbor Investment Advisory LLC boosted its stake in shares of Laboratory Corp. of America by 316.0% in the first quarter. Harbor Investment Advisory LLC now owns 208 shares of the medical research company’s stock worth $26,000 after acquiring an additional 158 shares during the period. Watson Rebecca bought a new position in shares of Laboratory Corp. of America in the second quarter worth about $32,000. Hoover Financial Advisors Inc. bought a new position in shares of Laboratory Corp. of America in the second quarter worth about $33,000. Finally, Jaffetilchin Investment Partners LLC bought a new position in shares of Laboratory Corp. of America in the second quarter worth about $42,000. Hedge funds and other institutional investors own 88.65% of the company’s stock.
Jul 23, 2019 Chevelle - Vitamin R (Leading Us Along) by CheVelle. Papercut (Official Video) - Linkin Park by Linkin Park. Slipknot - Duality OFFICIAL VIDEO. Aplikasi bersifat umum/general yang digunakan banyak user macintosh, pernah di request dan di share di thread ini 2. Siapa saja boleh share/bahas application disini 3. Jika ada pertanyaan dan request - silahkan posting saja di thread ini 4. Keep this thread clean - keep respect INSTALL AT YOUR OWN RISK:shakehand2. Vitamin-R شرایط بهینه را برای مغز شما به وجود می اورد تا مغز شما در بهترین شرایط خود کا کند که این امر به سبب وجود ساختار هایی است که کارهای شما را بدون هواس پرتی و با فعالیت هایی که با تمرکز بالا انجام می پذیرند به وجود می.
Vitamin R Lyrics
- Vitamin R (Leading Us Along) by CheVelle. So Cold by Breaking Benjamin. Gone Away by The Offspring. Polyamorous by Breaking Benjamin. Self-Esteem by The Offspring.
- Two Weeks Ago Last Week this Week Certification RIAA Pos Peak. Weeks On Chart-1.
Shares of NYSE:LH opened at $174.72 on Friday. Laboratory Corp. of America Holdings has a 52-week low of $98.02 and a 52-week high of $206.74. The stock has a market cap of $17.23 billion, a P/E ratio of 47.61, a price-to-earnings-growth ratio of 1.49 and a beta of 1.32. The business’s 50 day moving average is $188.79 and its 200 day moving average is $168.42. The company has a quick ratio of 1.01, a current ratio of 1.12 and a debt-to-equity ratio of 0.75.
Laboratory Corp. of America (NYSE:LH) last announced its quarterly earnings data on Tuesday, July 28th. The medical research company reported $2.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $1.79. Laboratory Corp. of America had a return on equity of 14.39% and a net margin of 3.16%. The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.44 billion. During the same quarter in the prior year, the firm earned $2.93 earnings per share. Laboratory Corp. of America’s revenue was down 3.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Laboratory Corp. of America Holdings will post 13.84 EPS for the current fiscal year.
LH has been the subject of a number of recent analyst reports. SunTrust Banks upped their price objective on Laboratory Corp. of America from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Wednesday, July 29th. Wells Fargo & Co reaffirmed a “buy” rating on shares of Laboratory Corp. of America in a research note on Wednesday, June 10th. Robert W. Baird upped their price objective on Laboratory Corp. of America from $199.00 to $219.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Zacks Investment Research downgraded Laboratory Corp. of America from a “strong-buy” rating to a “hold” rating and set a $206.00 target price on the stock. in a research report on Friday, July 31st. Finally, Mizuho boosted their target price on Laboratory Corp. of America from $186.00 to $215.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $214.44.
In other Laboratory Corp. of America news, EVP Der Vaart Sandra D. Van sold 872 shares of the stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $160.33, for a total transaction of $139,807.76. Following the sale, the executive vice president now owns 4,915 shares of the company’s stock, valued at approximately $788,021.95. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director R Sanders Williams sold 1,300 shares of the stock in a transaction on Wednesday, July 8th. The shares were sold at an average price of $173.12, for a total value of $225,056.00. Following the sale, the director now directly owns 6,395 shares in the company, valued at approximately $1,107,102.40. The disclosure for this sale can be found here. In the last three months, insiders sold 2,607 shares of company stock worth $438,814. 0.70% of the stock is owned by insiders.
Vitamin R Wiki
Laboratory Corp. of America Profile
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests.
Read More: Hedge Funds – How They Work For Investors
Vitamin R 2.57 List
![Sale Sale](/uploads/1/1/7/8/117885721/163100368.png)
Want to see what other hedge funds are holding LH?Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corp. of America Holdings (NYSE:LH).
Vitamin R Twilight
Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.